Highlights and Quick Summary
- EPS (Diluted, from Disc. Ops) for the quarter ending December 31, 2016 was $0.15 (a 650.0% increase compared to previous quarter)
- Year-over-year quarterly EPS (Diluted, from Disc. Ops) decreased by -188.24%
- Annual EPS (Diluted, from Disc. Ops) for 2016 was $-0.22 (a -63.93% decrease from previous year)
- Annual EPS (Diluted, from Disc. Ops) for 2015 was $-0.61 (a 60.53% increase from previous year)
- Twelve month EPS (Diluted, from Disc. Ops) ending December 31, 2016 was $-0.22 (a -74.71% decrease compared to previous quarter)
Trailing EPS (Diluted, from Disc. Ops) for the last four month:
| 31 Dec '16 | 30 Sep '16 | 30 Jun '16 | — |
|---|---|---|---|
| $-0.22 | $-0.87 | $-1 | — |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Diluted, from Disc. Ops) of Emergent Biosolutions Inc.
Most recent EPS (Diluted, from Disc. Ops)of EBS including historical data for past 10 years.Interactive Chart of EPS (Diluted, from Disc. Ops) of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. EPS (Diluted, from Disc. Ops) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2016 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2015 | – | – | $0.0 | $0.0 | $0.0 |
| 2014 | – | – | – | – | $0.0 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic